SlideShare a Scribd company logo
Abstract accepted for 6th Asian Pig Veterinary Society congress, Ho Chi Minh City, Vietnam, September 23-25, 2013 
INTRODUCTION OF PRSSV VACCINATION WITH PROGRESSIS® IN AN ITALIAN HERD VACCINATING SOWS WITH CIRCOVAC®: A CASE REPORT 
Francesco Salvini1, Giorgio Leotti2, François Joisel3 
1DMV, Brescia, Italy; 2MERIAL SpA Italia, Milano, Italy; 3MERIAL SAS, Lyon, France 
giorgio.leotti@merial.com 
Introduction 
This case report illustrates the benefits of modification in herd management practices and particularly the progressive introduction of PRSSv vaccination with PROGRESSIS ® in addition to PCV2 vaccination (CIRCOVAC ®) on reproductive performance in a well- managed operation located in Italy. 
Case Description 
The farm was a 1200-sow farrow-to-finish operation managed under a continuous flow management system. The gilts came from a self-replacement stock housed separately from the sows until their first farrowing. The herd was Aujeszky’s disease free and PRRSv positive as well as PCV2 positive. Key evolutions of herd management practices are reported in the table below (Table 1): 
Table 1. Schedule of events 
Period 
Operation 
2010-2012 
Progressive improvement of feed caracteristics 
2011/2012 
Weaning age delayed from 3 to 4 weeks of age 
End 2012 
Synchronization procedure abandoned 
February 2010 
CIRCOVAC vaccination implementation in gilts and sows according to the manufacturer recommandations 
2011 
PRRSv vaccination with PROGRESSIS introduced in gilts only (2 ml, IM, primo immunization in quarantine then one booster injection 70-80 days of gestation 
2012 
Sow mass vaccination with PROGRESSIS + one booster injection at 70-80 days of gestation 
2nd quarter 2012 
PROGRESSIS vaccination at 7of lactation and 70 days of gestation for each sow 
Average reproductive performances of the herd were extracted over three consecutive years from the farm monitoring software. 
Results and Discussion 
Fertility and prolificity data are described in Tables 2 & 3. 
The modifications introduced in reproductive cycle schedule led to a decrease of the number of parities per sow. The potential effect of desynchronizing estrus could not be clearly assessed since it occurred lately during the monitoring period. 
A clear lengthening of gestation duration was observed over the monitoring period as well as a definite improvement of the farrowing rate. Following the implementation of PRSSv vaccination in gilts, the farrowing rate in gilts increased from 82.8% to 90.8% at least; then following sows and gilts vaccination, a 92.3% farrowing rate was obtained for the whole herd. Consequently between 2010 and 2012, almost 10% improvement of the farrowing rate of the whole herd was obtained. 
Table 2. Fertility data over 3 consecutive years. 
2010/12 
2011/12 
2012/11* 
Total Nb of gilts or sows 
1116 
1044 
1123 
Nb AI 
3007 
2845 
2914 
Nb Gestation 
2507 
2540 
2690 
% 
83.4% 
89.3% 
92.3% 
Nb Abortion 
58 
40 
38 
% 
2.3% 
1.6% 
1.4% 
Nb AI (Gilts) 
711 
609 
638 
Nb Gestation (Gilts) 
589 
560 
579 
% (Gilts) 
82.8% 
92.0% 
90.8% 
Weaning-to-estrus interval 
6.77 
7.32 
6.24 
Days of gestation 
114.56 
115.41 
115.74 
Days of lactation 
24.64 
27.74 
28.11 
Interparity interval 
145.97 
150.47 
150.09 
Nb parity / year 
2.50 
2.43 
2.43 
*2012 records end in November. Nb=number 
Table 3. Prolificity data over 3 consecutive years. 
2010/12 
2011/12 
2012/11* 
Total born alive / litter 
13.26 
14.14 
15.01 
Total born alive / litter 
11.87 
12.84 
13.79 
Total weaned / litter 
9.94 
10.47 
11.28 
Total born alive / sow / year 
33.15 
34.29 
36.51 
Total born / sow / year 
29.68 
31.14 
33.53 
Total weaned / sow / year 
24.87 
25.4 
27.42 
Total born alive / year 
33241 
35905 
37231 
Total born / year 
29755 
32609 
34197 
Total weaned / year 
24931 
26600 
25619 
*2012 records end in November. 
Moreover, a clear and steadily improvement of prolificity indexes was observed. Particularly, litter size increased by 1.75 born alive piglets per litter between 2010 and 2012. 
Consequently the number of piglets weaned per dam increased from 24.87 to 27.42 following PRRSv vaccination implementation, despite the lengthening of the reproductive cycle. 
Conclusion 
This case report showed PRSSv vaccination implementation with PROGRESSIS in a herd vaccinating sows with CIRCOVAC as an effective tool to help improving fertility and prolificity parameters in a herd with good performances under Italian conditions. 
®PROGRESSIS and CIRCOVAC are registered trademarks of MERIAL in Italy and elsewhere.

More Related Content

Viewers also liked

Dr. Randall Prather - PRRS Resistant Pigs
Dr. Randall Prather - PRRS Resistant PigsDr. Randall Prather - PRRS Resistant Pigs
Dr. Randall Prather - PRRS Resistant Pigs
John Blue
 
Dr. Meggan Bandrick - Porcine Epidemic Diarrhea virus (PEDv) Vaccine, Path to...
Dr. Meggan Bandrick - Porcine Epidemic Diarrhea virus (PEDv) Vaccine, Path to...Dr. Meggan Bandrick - Porcine Epidemic Diarrhea virus (PEDv) Vaccine, Path to...
Dr. Meggan Bandrick - Porcine Epidemic Diarrhea virus (PEDv) Vaccine, Path to...
John Blue
 
Dr. Jay Calvert - Vaccination Against a Recently Emerged Virulent PRRS Virus ...
Dr. Jay Calvert - Vaccination Against a Recently Emerged Virulent PRRS Virus ...Dr. Jay Calvert - Vaccination Against a Recently Emerged Virulent PRRS Virus ...
Dr. Jay Calvert - Vaccination Against a Recently Emerged Virulent PRRS Virus ...
John Blue
 
Dr. David Wright, Dr. Bill Hartmann - PRRS & PEDV Control Proposal: Open Forum
Dr. David Wright, Dr. Bill Hartmann - PRRS & PEDV Control Proposal: Open ForumDr. David Wright, Dr. Bill Hartmann - PRRS & PEDV Control Proposal: Open Forum
Dr. David Wright, Dr. Bill Hartmann - PRRS & PEDV Control Proposal: Open Forum
John Blue
 
Dr. Bill Hollis - PRRS '174' virus - Field Experiences with Control and Manag...
Dr. Bill Hollis - PRRS '174' virus - Field Experiences with Control and Manag...Dr. Bill Hollis - PRRS '174' virus - Field Experiences with Control and Manag...
Dr. Bill Hollis - PRRS '174' virus - Field Experiences with Control and Manag...
John Blue
 
Dr. Andres Perez - PRRS Epidemiology: Best Principles of Control at a Regiona...
Dr. Andres Perez - PRRS Epidemiology: Best Principles of Control at a Regiona...Dr. Andres Perez - PRRS Epidemiology: Best Principles of Control at a Regiona...
Dr. Andres Perez - PRRS Epidemiology: Best Principles of Control at a Regiona...
John Blue
 
Dr. Julie Menard - What Would Dr. Leman Do... for PRRS
Dr. Julie Menard - What Would Dr. Leman Do... for PRRSDr. Julie Menard - What Would Dr. Leman Do... for PRRS
Dr. Julie Menard - What Would Dr. Leman Do... for PRRS
John Blue
 
Dr. Bryan Myers - Biosecurity of PRRS - pros and cons of air filtration
Dr. Bryan Myers - Biosecurity of PRRS - pros and cons of air filtrationDr. Bryan Myers - Biosecurity of PRRS - pros and cons of air filtration
Dr. Bryan Myers - Biosecurity of PRRS - pros and cons of air filtration
John Blue
 
Dr. Dale Polson - "Golden Rule" PRRS Control
Dr. Dale Polson - "Golden Rule" PRRS ControlDr. Dale Polson - "Golden Rule" PRRS Control
Dr. Dale Polson - "Golden Rule" PRRS Control
John Blue
 

Viewers also liked (9)

Dr. Randall Prather - PRRS Resistant Pigs
Dr. Randall Prather - PRRS Resistant PigsDr. Randall Prather - PRRS Resistant Pigs
Dr. Randall Prather - PRRS Resistant Pigs
 
Dr. Meggan Bandrick - Porcine Epidemic Diarrhea virus (PEDv) Vaccine, Path to...
Dr. Meggan Bandrick - Porcine Epidemic Diarrhea virus (PEDv) Vaccine, Path to...Dr. Meggan Bandrick - Porcine Epidemic Diarrhea virus (PEDv) Vaccine, Path to...
Dr. Meggan Bandrick - Porcine Epidemic Diarrhea virus (PEDv) Vaccine, Path to...
 
Dr. Jay Calvert - Vaccination Against a Recently Emerged Virulent PRRS Virus ...
Dr. Jay Calvert - Vaccination Against a Recently Emerged Virulent PRRS Virus ...Dr. Jay Calvert - Vaccination Against a Recently Emerged Virulent PRRS Virus ...
Dr. Jay Calvert - Vaccination Against a Recently Emerged Virulent PRRS Virus ...
 
Dr. David Wright, Dr. Bill Hartmann - PRRS & PEDV Control Proposal: Open Forum
Dr. David Wright, Dr. Bill Hartmann - PRRS & PEDV Control Proposal: Open ForumDr. David Wright, Dr. Bill Hartmann - PRRS & PEDV Control Proposal: Open Forum
Dr. David Wright, Dr. Bill Hartmann - PRRS & PEDV Control Proposal: Open Forum
 
Dr. Bill Hollis - PRRS '174' virus - Field Experiences with Control and Manag...
Dr. Bill Hollis - PRRS '174' virus - Field Experiences with Control and Manag...Dr. Bill Hollis - PRRS '174' virus - Field Experiences with Control and Manag...
Dr. Bill Hollis - PRRS '174' virus - Field Experiences with Control and Manag...
 
Dr. Andres Perez - PRRS Epidemiology: Best Principles of Control at a Regiona...
Dr. Andres Perez - PRRS Epidemiology: Best Principles of Control at a Regiona...Dr. Andres Perez - PRRS Epidemiology: Best Principles of Control at a Regiona...
Dr. Andres Perez - PRRS Epidemiology: Best Principles of Control at a Regiona...
 
Dr. Julie Menard - What Would Dr. Leman Do... for PRRS
Dr. Julie Menard - What Would Dr. Leman Do... for PRRSDr. Julie Menard - What Would Dr. Leman Do... for PRRS
Dr. Julie Menard - What Would Dr. Leman Do... for PRRS
 
Dr. Bryan Myers - Biosecurity of PRRS - pros and cons of air filtration
Dr. Bryan Myers - Biosecurity of PRRS - pros and cons of air filtrationDr. Bryan Myers - Biosecurity of PRRS - pros and cons of air filtration
Dr. Bryan Myers - Biosecurity of PRRS - pros and cons of air filtration
 
Dr. Dale Polson - "Golden Rule" PRRS Control
Dr. Dale Polson - "Golden Rule" PRRS ControlDr. Dale Polson - "Golden Rule" PRRS Control
Dr. Dale Polson - "Golden Rule" PRRS Control
 

Similar to Salvini et al.-Introduction of prssv vaccination with PROGRESSIS® in an italian herd vaccinatign sows with CIRCOVAC-in press

Vila et al. Improvement of herd performance parameters after sow and piglet v...
Vila et al. Improvement of herd performance parameters after sow and piglet v...Vila et al. Improvement of herd performance parameters after sow and piglet v...
Vila et al. Improvement of herd performance parameters after sow and piglet v...
Merial EMEA
 
01 maria nazare torres simoes
01 maria  nazare torres simoes01 maria  nazare torres simoes
01 maria nazare torres simoesMerial EMEA
 
Dr. Jean-Pierre Vaillancourt - Can You Keep High Path Avian Influenza from En...
Dr. Jean-Pierre Vaillancourt - Can You Keep High Path Avian Influenza from En...Dr. Jean-Pierre Vaillancourt - Can You Keep High Path Avian Influenza from En...
Dr. Jean-Pierre Vaillancourt - Can You Keep High Path Avian Influenza from En...
John Blue
 
Apvs2013 04 kagawa et al.-importance of continuation of pcv2 sow vaccination ...
Apvs2013 04 kagawa et al.-importance of continuation of pcv2 sow vaccination ...Apvs2013 04 kagawa et al.-importance of continuation of pcv2 sow vaccination ...
Apvs2013 04 kagawa et al.-importance of continuation of pcv2 sow vaccination ...Merial EMEA
 
FMD Impact and Cost Benefit Analysis - LEP Expo & Conference 2018, ICE BSD Ci...
FMD Impact and Cost Benefit Analysis - LEP Expo & Conference 2018, ICE BSD Ci...FMD Impact and Cost Benefit Analysis - LEP Expo & Conference 2018, ICE BSD Ci...
FMD Impact and Cost Benefit Analysis - LEP Expo & Conference 2018, ICE BSD Ci...
Tata Naipospos
 
PERTUSSIS PROTECTION - CURRENT SCHEDULES IN EUROPE
PERTUSSIS PROTECTION - CURRENT SCHEDULES IN EUROPEPERTUSSIS PROTECTION - CURRENT SCHEDULES IN EUROPE
PERTUSSIS PROTECTION - CURRENT SCHEDULES IN EUROPE
WAidid
 
Ross note mycoplasmosis-en-19
Ross note mycoplasmosis-en-19Ross note mycoplasmosis-en-19
Ross note mycoplasmosis-en-19
sarojdr127
 
Assessment of productive and reproductive performances of cross
Assessment of productive and reproductive performances of crossAssessment of productive and reproductive performances of cross
Assessment of productive and reproductive performances of crossAlexander Decker
 
Assessment of productive and reproductive performances of cross
Assessment of productive and reproductive performances of crossAssessment of productive and reproductive performances of cross
Assessment of productive and reproductive performances of crossAlexander Decker
 
Prevention and control of Mycoplasma sinoviae without vaccination
Prevention and control of Mycoplasma sinoviae without vaccinationPrevention and control of Mycoplasma sinoviae without vaccination
Prevention and control of Mycoplasma sinoviae without vaccination
Rafael Monleon
 
Rotavirus prevention and control
Rotavirus prevention and controlRotavirus prevention and control
Rotavirus prevention and controlSimba Takuva
 
MANAGEMENTAL STRATEGIES FOR REDUCING CALVING INTERVAL IN FARM ANIMALS by Dr B...
MANAGEMENTAL STRATEGIES FOR REDUCING CALVING INTERVAL IN FARM ANIMALS by Dr B...MANAGEMENTAL STRATEGIES FOR REDUCING CALVING INTERVAL IN FARM ANIMALS by Dr B...
MANAGEMENTAL STRATEGIES FOR REDUCING CALVING INTERVAL IN FARM ANIMALS by Dr B...
sri venkateshwara veterinary university
 
LIFE CYCLE AND LARVAL PERFORMANCE OF THE JOKER BYBLIA ILITHYIA (LEPIDOPTERA: ...
LIFE CYCLE AND LARVAL PERFORMANCE OF THE JOKER BYBLIA ILITHYIA (LEPIDOPTERA: ...LIFE CYCLE AND LARVAL PERFORMANCE OF THE JOKER BYBLIA ILITHYIA (LEPIDOPTERA: ...
LIFE CYCLE AND LARVAL PERFORMANCE OF THE JOKER BYBLIA ILITHYIA (LEPIDOPTERA: ...
Dr Palem Harinath Reddy
 
Risk factors affecting parturition and neonatal mortality: a retrospective st...
Risk factors affecting parturition and neonatal mortality: a retrospective st...Risk factors affecting parturition and neonatal mortality: a retrospective st...
Risk factors affecting parturition and neonatal mortality: a retrospective st...
Emmanuel Fontaine
 
Modeling the Ebola Outbreak in West Africa, January 27th 2015 update
Modeling the Ebola Outbreak in West Africa, January 27th 2015 updateModeling the Ebola Outbreak in West Africa, January 27th 2015 update
Modeling the Ebola Outbreak in West Africa, January 27th 2015 update
Biocomplexity Institute of Virginia Tech
 
Study of Incidence and Etiology of Prolapse at Rural Based Teaching Hospital
Study of Incidence and Etiology of Prolapse at Rural Based Teaching HospitalStudy of Incidence and Etiology of Prolapse at Rural Based Teaching Hospital
Study of Incidence and Etiology of Prolapse at Rural Based Teaching Hospital
theijes
 
Recent_Possibilities_for_Diagnosis_and_Treatment_o.pdf
Recent_Possibilities_for_Diagnosis_and_Treatment_o.pdfRecent_Possibilities_for_Diagnosis_and_Treatment_o.pdf
Recent_Possibilities_for_Diagnosis_and_Treatment_o.pdf
LnTrnVn
 

Similar to Salvini et al.-Introduction of prssv vaccination with PROGRESSIS® in an italian herd vaccinatign sows with CIRCOVAC-in press (20)

Vila et al. Improvement of herd performance parameters after sow and piglet v...
Vila et al. Improvement of herd performance parameters after sow and piglet v...Vila et al. Improvement of herd performance parameters after sow and piglet v...
Vila et al. Improvement of herd performance parameters after sow and piglet v...
 
01 maria nazare torres simoes
01 maria  nazare torres simoes01 maria  nazare torres simoes
01 maria nazare torres simoes
 
Dr. Jean-Pierre Vaillancourt - Can You Keep High Path Avian Influenza from En...
Dr. Jean-Pierre Vaillancourt - Can You Keep High Path Avian Influenza from En...Dr. Jean-Pierre Vaillancourt - Can You Keep High Path Avian Influenza from En...
Dr. Jean-Pierre Vaillancourt - Can You Keep High Path Avian Influenza from En...
 
Apvs2013 04 kagawa et al.-importance of continuation of pcv2 sow vaccination ...
Apvs2013 04 kagawa et al.-importance of continuation of pcv2 sow vaccination ...Apvs2013 04 kagawa et al.-importance of continuation of pcv2 sow vaccination ...
Apvs2013 04 kagawa et al.-importance of continuation of pcv2 sow vaccination ...
 
FMD Impact and Cost Benefit Analysis - LEP Expo & Conference 2018, ICE BSD Ci...
FMD Impact and Cost Benefit Analysis - LEP Expo & Conference 2018, ICE BSD Ci...FMD Impact and Cost Benefit Analysis - LEP Expo & Conference 2018, ICE BSD Ci...
FMD Impact and Cost Benefit Analysis - LEP Expo & Conference 2018, ICE BSD Ci...
 
PERTUSSIS PROTECTION - CURRENT SCHEDULES IN EUROPE
PERTUSSIS PROTECTION - CURRENT SCHEDULES IN EUROPEPERTUSSIS PROTECTION - CURRENT SCHEDULES IN EUROPE
PERTUSSIS PROTECTION - CURRENT SCHEDULES IN EUROPE
 
Ross note mycoplasmosis-en-19
Ross note mycoplasmosis-en-19Ross note mycoplasmosis-en-19
Ross note mycoplasmosis-en-19
 
02 henry too
02 henry too02 henry too
02 henry too
 
Assessment of productive and reproductive performances of cross
Assessment of productive and reproductive performances of crossAssessment of productive and reproductive performances of cross
Assessment of productive and reproductive performances of cross
 
Assessment of productive and reproductive performances of cross
Assessment of productive and reproductive performances of crossAssessment of productive and reproductive performances of cross
Assessment of productive and reproductive performances of cross
 
FIVNATCH10
FIVNATCH10FIVNATCH10
FIVNATCH10
 
Prevention and control of Mycoplasma sinoviae without vaccination
Prevention and control of Mycoplasma sinoviae without vaccinationPrevention and control of Mycoplasma sinoviae without vaccination
Prevention and control of Mycoplasma sinoviae without vaccination
 
Rotavirus prevention and control
Rotavirus prevention and controlRotavirus prevention and control
Rotavirus prevention and control
 
MANAGEMENTAL STRATEGIES FOR REDUCING CALVING INTERVAL IN FARM ANIMALS by Dr B...
MANAGEMENTAL STRATEGIES FOR REDUCING CALVING INTERVAL IN FARM ANIMALS by Dr B...MANAGEMENTAL STRATEGIES FOR REDUCING CALVING INTERVAL IN FARM ANIMALS by Dr B...
MANAGEMENTAL STRATEGIES FOR REDUCING CALVING INTERVAL IN FARM ANIMALS by Dr B...
 
thesis final ppt
thesis final pptthesis final ppt
thesis final ppt
 
LIFE CYCLE AND LARVAL PERFORMANCE OF THE JOKER BYBLIA ILITHYIA (LEPIDOPTERA: ...
LIFE CYCLE AND LARVAL PERFORMANCE OF THE JOKER BYBLIA ILITHYIA (LEPIDOPTERA: ...LIFE CYCLE AND LARVAL PERFORMANCE OF THE JOKER BYBLIA ILITHYIA (LEPIDOPTERA: ...
LIFE CYCLE AND LARVAL PERFORMANCE OF THE JOKER BYBLIA ILITHYIA (LEPIDOPTERA: ...
 
Risk factors affecting parturition and neonatal mortality: a retrospective st...
Risk factors affecting parturition and neonatal mortality: a retrospective st...Risk factors affecting parturition and neonatal mortality: a retrospective st...
Risk factors affecting parturition and neonatal mortality: a retrospective st...
 
Modeling the Ebola Outbreak in West Africa, January 27th 2015 update
Modeling the Ebola Outbreak in West Africa, January 27th 2015 updateModeling the Ebola Outbreak in West Africa, January 27th 2015 update
Modeling the Ebola Outbreak in West Africa, January 27th 2015 update
 
Study of Incidence and Etiology of Prolapse at Rural Based Teaching Hospital
Study of Incidence and Etiology of Prolapse at Rural Based Teaching HospitalStudy of Incidence and Etiology of Prolapse at Rural Based Teaching Hospital
Study of Incidence and Etiology of Prolapse at Rural Based Teaching Hospital
 
Recent_Possibilities_for_Diagnosis_and_Treatment_o.pdf
Recent_Possibilities_for_Diagnosis_and_Treatment_o.pdfRecent_Possibilities_for_Diagnosis_and_Treatment_o.pdf
Recent_Possibilities_for_Diagnosis_and_Treatment_o.pdf
 

More from Merial EMEA

VAXXITEK HVT + IBD - Field Study - Spain - Merial
VAXXITEK HVT + IBD - Field Study - Spain - MerialVAXXITEK HVT + IBD - Field Study - Spain - Merial
VAXXITEK HVT + IBD - Field Study - Spain - Merial
Merial EMEA
 
VAXXITEK HVT + IBD - Field Study - Brazil - Merial
VAXXITEK HVT + IBD - Field Study - Brazil - MerialVAXXITEK HVT + IBD - Field Study - Brazil - Merial
VAXXITEK HVT + IBD - Field Study - Brazil - Merial
Merial EMEA
 
VAXXITEK HVT + IBD - Field Study - Egypt - Merial
VAXXITEK HVT + IBD - Field Study - Egypt - MerialVAXXITEK HVT + IBD - Field Study - Egypt - Merial
VAXXITEK HVT + IBD - Field Study - Egypt - Merial
Merial EMEA
 
VAXXITEK HVT + IBD - Field Study - China - Merial
VAXXITEK HVT + IBD - Field Study - China - MerialVAXXITEK HVT + IBD - Field Study - China - Merial
VAXXITEK HVT + IBD - Field Study - China - Merial
Merial EMEA
 
VAXXITEK HVT + IBD - Field Study - United Kingdom - Merial
VAXXITEK HVT + IBD - Field Study - United Kingdom - MerialVAXXITEK HVT + IBD - Field Study - United Kingdom - Merial
VAXXITEK HVT + IBD - Field Study - United Kingdom - Merial
Merial EMEA
 
VAXXITEK HVT + IBD - Field Study - France - Merial
VAXXITEK HVT + IBD - Field Study - France - MerialVAXXITEK HVT + IBD - Field Study - France - Merial
VAXXITEK HVT + IBD - Field Study - France - Merial
Merial EMEA
 
Apvs2013 09 vosloo et al.-o1 manisa efficacy vs viet fmd strain in pig
Apvs2013 09 vosloo et al.-o1 manisa efficacy vs viet fmd strain in pigApvs2013 09 vosloo et al.-o1 manisa efficacy vs viet fmd strain in pig
Apvs2013 09 vosloo et al.-o1 manisa efficacy vs viet fmd strain in pigMerial EMEA
 
Chapat et al.-orf1 et orf2 cmi with CIRCOVAC vaccination in sows
Chapat et al.-orf1 et orf2 cmi with CIRCOVAC vaccination in sowsChapat et al.-orf1 et orf2 cmi with CIRCOVAC vaccination in sows
Chapat et al.-orf1 et orf2 cmi with CIRCOVAC vaccination in sows
Merial EMEA
 
Apvs2013 02 merdy et al.-comparison circovac vs competitors on adwg mortality...
Apvs2013 02 merdy et al.-comparison circovac vs competitors on adwg mortality...Apvs2013 02 merdy et al.-comparison circovac vs competitors on adwg mortality...
Apvs2013 02 merdy et al.-comparison circovac vs competitors on adwg mortality...Merial EMEA
 
Apvs2013 01 merdy et al.-circovac pmr calculation
Apvs2013 01 merdy et al.-circovac pmr calculationApvs2013 01 merdy et al.-circovac pmr calculation
Apvs2013 01 merdy et al.-circovac pmr calculationMerial EMEA
 
Apvs2013 10 lee et al.-trypanosomiasis in pigs in malaysia
Apvs2013 10 lee et al.-trypanosomiasis in pigs in malaysiaApvs2013 10 lee et al.-trypanosomiasis in pigs in malaysia
Apvs2013 10 lee et al.-trypanosomiasis in pigs in malaysiaMerial EMEA
 
Apvs2013 08 tee et al.-csf test kit comparison
Apvs2013 08 tee et al.-csf test kit comparisonApvs2013 08 tee et al.-csf test kit comparison
Apvs2013 08 tee et al.-csf test kit comparisonMerial EMEA
 
Apvs2013 06 castellan et al.-clinical case report of h1 n1pdm in italy
Apvs2013 06 castellan et al.-clinical case report of h1 n1pdm in italyApvs2013 06 castellan et al.-clinical case report of h1 n1pdm in italy
Apvs2013 06 castellan et al.-clinical case report of h1 n1pdm in italyMerial EMEA
 
Aasv2014 daresta et al. comparative pcv2 fetal protection-poster
Aasv2014 daresta et al. comparative pcv2 fetal protection-posterAasv2014 daresta et al. comparative pcv2 fetal protection-poster
Aasv2014 daresta et al. comparative pcv2 fetal protection-posterMerial EMEA
 
Aasv2014 callen et al. vaccination compliance to pcv2 using a dth test
Aasv2014 callen et al. vaccination compliance to pcv2 using a dth testAasv2014 callen et al. vaccination compliance to pcv2 using a dth test
Aasv2014 callen et al. vaccination compliance to pcv2 using a dth testMerial EMEA
 
Ipvs2014 02 mortensen et al.-pcv2 circulation control in danish fatteners abs...
Ipvs2014 02 mortensen et al.-pcv2 circulation control in danish fatteners abs...Ipvs2014 02 mortensen et al.-pcv2 circulation control in danish fatteners abs...
Ipvs2014 02 mortensen et al.-pcv2 circulation control in danish fatteners abs...Merial EMEA
 
Ipvs2014 01 chapat et al-preliminary results cmi circovac piglets abstract
Ipvs2014 01 chapat et al-preliminary results cmi circovac piglets abstractIpvs2014 01 chapat et al-preliminary results cmi circovac piglets abstract
Ipvs2014 01 chapat et al-preliminary results cmi circovac piglets abstractMerial EMEA
 
12 merialberlinhansnauwynck
12 merialberlinhansnauwynck12 merialberlinhansnauwynck
12 merialberlinhansnauwynckMerial EMEA
 
05 flu kvd meulen
05 flu kvd meulen05 flu kvd meulen
05 flu kvd meulenMerial EMEA
 

More from Merial EMEA (20)

VAXXITEK HVT + IBD - Field Study - Spain - Merial
VAXXITEK HVT + IBD - Field Study - Spain - MerialVAXXITEK HVT + IBD - Field Study - Spain - Merial
VAXXITEK HVT + IBD - Field Study - Spain - Merial
 
VAXXITEK HVT + IBD - Field Study - Brazil - Merial
VAXXITEK HVT + IBD - Field Study - Brazil - MerialVAXXITEK HVT + IBD - Field Study - Brazil - Merial
VAXXITEK HVT + IBD - Field Study - Brazil - Merial
 
VAXXITEK HVT + IBD - Field Study - Egypt - Merial
VAXXITEK HVT + IBD - Field Study - Egypt - MerialVAXXITEK HVT + IBD - Field Study - Egypt - Merial
VAXXITEK HVT + IBD - Field Study - Egypt - Merial
 
VAXXITEK HVT + IBD - Field Study - China - Merial
VAXXITEK HVT + IBD - Field Study - China - MerialVAXXITEK HVT + IBD - Field Study - China - Merial
VAXXITEK HVT + IBD - Field Study - China - Merial
 
VAXXITEK HVT + IBD - Field Study - United Kingdom - Merial
VAXXITEK HVT + IBD - Field Study - United Kingdom - MerialVAXXITEK HVT + IBD - Field Study - United Kingdom - Merial
VAXXITEK HVT + IBD - Field Study - United Kingdom - Merial
 
VAXXITEK HVT + IBD - Field Study - France - Merial
VAXXITEK HVT + IBD - Field Study - France - MerialVAXXITEK HVT + IBD - Field Study - France - Merial
VAXXITEK HVT + IBD - Field Study - France - Merial
 
Apvs2013 09 vosloo et al.-o1 manisa efficacy vs viet fmd strain in pig
Apvs2013 09 vosloo et al.-o1 manisa efficacy vs viet fmd strain in pigApvs2013 09 vosloo et al.-o1 manisa efficacy vs viet fmd strain in pig
Apvs2013 09 vosloo et al.-o1 manisa efficacy vs viet fmd strain in pig
 
Chapat et al.-orf1 et orf2 cmi with CIRCOVAC vaccination in sows
Chapat et al.-orf1 et orf2 cmi with CIRCOVAC vaccination in sowsChapat et al.-orf1 et orf2 cmi with CIRCOVAC vaccination in sows
Chapat et al.-orf1 et orf2 cmi with CIRCOVAC vaccination in sows
 
Apvs2013 02 merdy et al.-comparison circovac vs competitors on adwg mortality...
Apvs2013 02 merdy et al.-comparison circovac vs competitors on adwg mortality...Apvs2013 02 merdy et al.-comparison circovac vs competitors on adwg mortality...
Apvs2013 02 merdy et al.-comparison circovac vs competitors on adwg mortality...
 
Apvs2013 01 merdy et al.-circovac pmr calculation
Apvs2013 01 merdy et al.-circovac pmr calculationApvs2013 01 merdy et al.-circovac pmr calculation
Apvs2013 01 merdy et al.-circovac pmr calculation
 
Apvs2013 10 lee et al.-trypanosomiasis in pigs in malaysia
Apvs2013 10 lee et al.-trypanosomiasis in pigs in malaysiaApvs2013 10 lee et al.-trypanosomiasis in pigs in malaysia
Apvs2013 10 lee et al.-trypanosomiasis in pigs in malaysia
 
Apvs2013 08 tee et al.-csf test kit comparison
Apvs2013 08 tee et al.-csf test kit comparisonApvs2013 08 tee et al.-csf test kit comparison
Apvs2013 08 tee et al.-csf test kit comparison
 
Apvs2013 06 castellan et al.-clinical case report of h1 n1pdm in italy
Apvs2013 06 castellan et al.-clinical case report of h1 n1pdm in italyApvs2013 06 castellan et al.-clinical case report of h1 n1pdm in italy
Apvs2013 06 castellan et al.-clinical case report of h1 n1pdm in italy
 
Aasv2014 daresta et al. comparative pcv2 fetal protection-poster
Aasv2014 daresta et al. comparative pcv2 fetal protection-posterAasv2014 daresta et al. comparative pcv2 fetal protection-poster
Aasv2014 daresta et al. comparative pcv2 fetal protection-poster
 
Aasv2014 callen et al. vaccination compliance to pcv2 using a dth test
Aasv2014 callen et al. vaccination compliance to pcv2 using a dth testAasv2014 callen et al. vaccination compliance to pcv2 using a dth test
Aasv2014 callen et al. vaccination compliance to pcv2 using a dth test
 
Ipvs2014 02 mortensen et al.-pcv2 circulation control in danish fatteners abs...
Ipvs2014 02 mortensen et al.-pcv2 circulation control in danish fatteners abs...Ipvs2014 02 mortensen et al.-pcv2 circulation control in danish fatteners abs...
Ipvs2014 02 mortensen et al.-pcv2 circulation control in danish fatteners abs...
 
Ipvs2014 01 chapat et al-preliminary results cmi circovac piglets abstract
Ipvs2014 01 chapat et al-preliminary results cmi circovac piglets abstractIpvs2014 01 chapat et al-preliminary results cmi circovac piglets abstract
Ipvs2014 01 chapat et al-preliminary results cmi circovac piglets abstract
 
12 merialberlinhansnauwynck
12 merialberlinhansnauwynck12 merialberlinhansnauwynck
12 merialberlinhansnauwynck
 
05 flu s lee
05 flu s lee05 flu s lee
05 flu s lee
 
05 flu kvd meulen
05 flu kvd meulen05 flu kvd meulen
05 flu kvd meulen
 

Salvini et al.-Introduction of prssv vaccination with PROGRESSIS® in an italian herd vaccinatign sows with CIRCOVAC-in press

  • 1. Abstract accepted for 6th Asian Pig Veterinary Society congress, Ho Chi Minh City, Vietnam, September 23-25, 2013 INTRODUCTION OF PRSSV VACCINATION WITH PROGRESSIS® IN AN ITALIAN HERD VACCINATING SOWS WITH CIRCOVAC®: A CASE REPORT Francesco Salvini1, Giorgio Leotti2, François Joisel3 1DMV, Brescia, Italy; 2MERIAL SpA Italia, Milano, Italy; 3MERIAL SAS, Lyon, France giorgio.leotti@merial.com Introduction This case report illustrates the benefits of modification in herd management practices and particularly the progressive introduction of PRSSv vaccination with PROGRESSIS ® in addition to PCV2 vaccination (CIRCOVAC ®) on reproductive performance in a well- managed operation located in Italy. Case Description The farm was a 1200-sow farrow-to-finish operation managed under a continuous flow management system. The gilts came from a self-replacement stock housed separately from the sows until their first farrowing. The herd was Aujeszky’s disease free and PRRSv positive as well as PCV2 positive. Key evolutions of herd management practices are reported in the table below (Table 1): Table 1. Schedule of events Period Operation 2010-2012 Progressive improvement of feed caracteristics 2011/2012 Weaning age delayed from 3 to 4 weeks of age End 2012 Synchronization procedure abandoned February 2010 CIRCOVAC vaccination implementation in gilts and sows according to the manufacturer recommandations 2011 PRRSv vaccination with PROGRESSIS introduced in gilts only (2 ml, IM, primo immunization in quarantine then one booster injection 70-80 days of gestation 2012 Sow mass vaccination with PROGRESSIS + one booster injection at 70-80 days of gestation 2nd quarter 2012 PROGRESSIS vaccination at 7of lactation and 70 days of gestation for each sow Average reproductive performances of the herd were extracted over three consecutive years from the farm monitoring software. Results and Discussion Fertility and prolificity data are described in Tables 2 & 3. The modifications introduced in reproductive cycle schedule led to a decrease of the number of parities per sow. The potential effect of desynchronizing estrus could not be clearly assessed since it occurred lately during the monitoring period. A clear lengthening of gestation duration was observed over the monitoring period as well as a definite improvement of the farrowing rate. Following the implementation of PRSSv vaccination in gilts, the farrowing rate in gilts increased from 82.8% to 90.8% at least; then following sows and gilts vaccination, a 92.3% farrowing rate was obtained for the whole herd. Consequently between 2010 and 2012, almost 10% improvement of the farrowing rate of the whole herd was obtained. Table 2. Fertility data over 3 consecutive years. 2010/12 2011/12 2012/11* Total Nb of gilts or sows 1116 1044 1123 Nb AI 3007 2845 2914 Nb Gestation 2507 2540 2690 % 83.4% 89.3% 92.3% Nb Abortion 58 40 38 % 2.3% 1.6% 1.4% Nb AI (Gilts) 711 609 638 Nb Gestation (Gilts) 589 560 579 % (Gilts) 82.8% 92.0% 90.8% Weaning-to-estrus interval 6.77 7.32 6.24 Days of gestation 114.56 115.41 115.74 Days of lactation 24.64 27.74 28.11 Interparity interval 145.97 150.47 150.09 Nb parity / year 2.50 2.43 2.43 *2012 records end in November. Nb=number Table 3. Prolificity data over 3 consecutive years. 2010/12 2011/12 2012/11* Total born alive / litter 13.26 14.14 15.01 Total born alive / litter 11.87 12.84 13.79 Total weaned / litter 9.94 10.47 11.28 Total born alive / sow / year 33.15 34.29 36.51 Total born / sow / year 29.68 31.14 33.53 Total weaned / sow / year 24.87 25.4 27.42 Total born alive / year 33241 35905 37231 Total born / year 29755 32609 34197 Total weaned / year 24931 26600 25619 *2012 records end in November. Moreover, a clear and steadily improvement of prolificity indexes was observed. Particularly, litter size increased by 1.75 born alive piglets per litter between 2010 and 2012. Consequently the number of piglets weaned per dam increased from 24.87 to 27.42 following PRRSv vaccination implementation, despite the lengthening of the reproductive cycle. Conclusion This case report showed PRSSv vaccination implementation with PROGRESSIS in a herd vaccinating sows with CIRCOVAC as an effective tool to help improving fertility and prolificity parameters in a herd with good performances under Italian conditions. ®PROGRESSIS and CIRCOVAC are registered trademarks of MERIAL in Italy and elsewhere.